← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUROFARMA · Approved 2007-06-29

Drug application

FDA Application #

ANDA065316

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

Ampicillin Sodium

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

EUROFARMA

First approval

2007-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown